Fine Fettle, a leading cannabis operator in Connecticut, has introduced AURA, a premium disposable vape brand designed for both medical patients and adult-use customers. Launching statewide on March 27, 2026, at Fine Fettle dispensaries and partner retailers, AURA addresses key frustrations in the disposable vape market while prioritizing flavor purity and reliability—elevating standards in a rapidly growing industry.
Superior Hardware Tackles Common Vape Shortcomings
AURA stands out with hardware engineered to solve persistent issues like flavor degradation, inconsistent heating, and poor oil efficiency. Unlike conventional disposables that use metal cores prone to leaching or clogging, AURA employs an all-glass tank paired with a ceramic atomizer and no metal oil chamber. This setup ensures a pristine vapor path via dual-airflow design, preserving terpenes for authentic taste and delivering uniform heat across its 1g rechargeable capacity.
- Cleaner vapor reduces potential irritants, appealing to health-conscious medical users seeking symptom relief without harsh byproducts.
- Enhanced oil utilization minimizes waste, aligning with sustainability trends in cannabis consumption.
- Rechargeable feature extends usability, countering the single-use environmental concerns plaguing disposables.
High-Quality Oils and Curated Strains
Crafted from Connecticut-sourced distillate by Fine Fettle Brands, AURA emphasizes purity through refined processes that yield smooth, potent vapor. Initial offerings feature a diverse strain lineup blending flavor profiles—like citrusy hybrids or earthy indicas—with targeted effects, from relaxation to focus. This consistency empowers users to select reliably, fostering trust in a market often criticized for variability.
"AURA was built with intention at every level—from the oil inside to the hardware that delivers it," states Fine Fettle CEO Ben Zachs. He highlights eliminating compromises for "clean vapor, reliability, and consistent performance," reflecting the company's innovation drive.
Broader Implications for Connecticut's Cannabis Landscape
Connecticut's adult-use market, legalized in 2021, has surged with dispensary sales topping $200 million annually by 2025, yet consumers demand better products amid rising competition. AURA's debut signals a shift toward premium disposables, potentially pressuring rivals to innovate while benefiting medical patients who comprise 30% of the state's cannabis base. By focusing on terpene integrity and clean tech, it taps into health trends favoring inhalation methods with minimal contaminants, possibly reducing black-market reliance and supporting regulated growth.
As Zachs notes, AURA injects "fresh energy" into Fine Fettle's portfolio, underscoring a commitment to quality that could set new benchmarks for safety and satisfaction in the evolving vape sector.
